Likarda wins Innovation Award at Boston Chinese Investment Club 2023 Biomedical Pitch Competition

At the Boston Chinese Investment Club (BCIC) 2023 Biomedical Pitch Competition in April, Likarda was amongst a dozen chosen companies to advance to the top round of pitches. Designed to bring together bio-tech innovators and potential investors and resources and fast-track the networking process, this event started with 86 initial pitches in March and April.¬† Likarda’s strong pitch for their Core Shell Spherification microencapsulation delivery system was awarded the show’s Innovation Award.¬†Likarda’s Core Shell Spherification (CSS) is able to utilize the body’s inert materials, so the body is less likely to react with an inflammatory response.